The Indiana Myeloma Registry

Description

This is a prospective, non-interventional, observational study. The purpose of this study is to collect data and bio-specimens that will support future research

Conditions

Plasma Cell Dyscrasias

Talk to us

Study Overview

On this page

Study Details

Study overview

This is a prospective, non-interventional, observational study. The purpose of this study is to collect data and bio-specimens that will support future research

Collection of Specimens and Clinical Data to Create A Bio-repository for the Multiple Myeloma Program: The Indiana Myeloma Registry

The Indiana Myeloma Registry

Condition
Plasma Cell Dyscrasias
Intervention / Treatment

-

Contacts and Locations

Indianapolis

Indiana University Simon Cancer Center, Indianapolis, Indiana, United States, 46202

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Male or female patients ≥ 18 years of age at the time of informed consent
  • 2. Has been diagnosed with or is suspected to have one of the following:
  • 1. Monoclonal Gammopathy of Undetermined Significance (MGUS)
  • 2. Smoldering Multiple Myeloma
  • 3. Multiple Myeloma
  • 4. Bony or Soft Tissue Plasmacytoma
  • 5. Primary Amyloidosis

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Indiana University,

Rafat Abonour, MD, PRINCIPAL_INVESTIGATOR, Indiana University School of Medicine

Study Record Dates

2028-06-30